Integra LifeSciences Reports 1Q19 Orthopedic Revenue of $22.7MM, +0.2% vs. 1Q18

Integra LifeSciences reported 1Q19 orthopedic revenue of USD $22.7MM, +0.2% vs. 1Q18.

• Achieved growth one quarter ahead of schedule, as orthopedics were expected to generate revenue growth in the second half of 2019
• Introduction of new products and improved salesforce effectiveness drove growth
• New products included Titan Reverse Shoulder and Panta 2 Arthrodesis Nail systems
• Double-digit growth in ankle and shoulder products (the latter +20%)
• EMEA sales declined due to expected disruption during ERP conversion

Segment sales and growth on an as-reported basis are as follows ($MM).

Sales by geographic region are as follows ($MM).

Net earnings, inclusive of all revenue, are as follows.

Sources: Integra LifeSciences; ORTHOWORLD estimates.

Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.